EPTIS
BAM Logo

ELQA - Specific Immunology

[ELQA - Ειδικός Ανοσολογικός Έλεγχος]

EPTIS factsheet 840621 | Last revision 2021-05-10 | URL: https://www.eptis.bam.de/pts840621 https://www.eptis.bam.de/pts840621

PT provider
PT provider ELQA ELQA
Based in Greece
Language(s) English
Remarks
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
Sera of human origin, lyophilized HBsAg, (Rubella) IgG, (Rubella) IgM, HIV I & II, anti-toxo IgG, anti-toxo IgM, (CMV) IgG, (CMV) IgM, Anti-HBs, Anti-HBc, Anti-HCV, Anti-HAV IgG -
Aims of the PT scheme
Target group of participants Diagnostic Laboratories
Linked to specific legislation / standards
Additional, subsidiary aims validation of testing methods
Number of participants Min. no of participants : 6
Accredited or otherwise reviewed by a 3rd party

Accredited by ESYD, the Greek Accreditation Body on the basis of ISO 17043:2010 (Certificate No 1130)

Operation is commissioned / requested by
Fees and frequency
Participation fee 110 Euro + Vat
Regularly operated Yes (bimonthly)
Year of first operation 2016
Contact details of the PT provider
Provider Contact person
ELQA
PEO Larissa - Trikala
41110 Larissa
Greece

Phone: +302410684448
Fax: +302410684650
Web: http://www.elqa.gr http://www.elqa.gr
Dr. Agelos Papaioannou
Phone: +302410684448
Fax: +302410684650
Email: elqa@elqa.gr elqa@elqa.gr
If you find any mistakes please contact the responsible EPTIS coordinator in Greece, Ms Vicky Nikou. Ms Vicky Nikou.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.21